Kolexia
Hachulla Eric Médecine interne
Hachulla Eric
Médecine interne
Hôpital Huriez
Lille, France
917 Activités
219 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérodermie systémique Sclérose Maladies auto-immunes Syndrome de Gougerot-Sjögren Lupus érythémateux disséminé Sclérodermie localisée Hypertension artérielle Maladies pulmonaires Pneumopathies interstitielles

Collaborateurs

Voir plus
Launay David
Launay David
Hôpital Huriez, Lille, France
Hatron Pierre-Yves
Hatron Pierre-Yves
Hôpital Huriez, Lille, France
Mouthon Luc
Mouthon Luc
Hôpital Cochin, Paris, France
Lambert Marc
Lambert Marc
Hôpital Huriez, Lille, France

Industries

Voir plus
GSK
35 collaboration(s)
Dernière en 2023
RE-IMAGINE Health Agency
18 collaboration(s)
Dernière en 2021
Boehringer Ingelheim
16 collaboration(s)
Dernière en 2023
AstraZeneca
16 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ESRA: Efficacy and Safety of Riociguat (MK-4836) in Incipient Pulmonary Vascular Disease as an Indicator for Early Pulmonary Arterial Hypertension Double-blind, Randomized, Multicenter, Multinational, Placebo-controlled Phase IIa Study (ESRA)
Essai Clinique (Merck & Co.)   13 mars 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford, England)   09 mars 2024
Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis.
Rheumatology (Oxford, England)   07 mars 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
The Lancet. Rheumatology   01 mars 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.
Rheumatology (Oxford, England)   01 mars 2024
Characterisation of airway disease associated with Sjögren disease.
RMD open   29 février 2024
A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis: A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
Essai Clinique (Horizon Therapeutics Ireland DAC)   28 février 2024
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE): A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus
Essai Clinique (BMS)   26 février 2024
Targeting CCR4 with mogamulizumab in refractory CD3-CD4 lymphocytic-variant hypereosinophilic syndrome.
Haematologica   08 février 2024
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.
Diagnostics (Basel, Switzerland)   30 janvier 2024